Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1

Conditions

Urinary Bladder Neoplasms 3Ovarian Neoplasms 3Thyroid Neoplasms 2Sarcoma 2Parathyroid Neoplasms 2Otorhinolaryngologic Neoplasms 2Osteosarcoma 2Mixed Tumor, Mesodermal 2Mesothelioma, Cystic 2Mesothelioma 2Lung Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Chondrosarcoma 2Carcinoma, Small Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Adenosarcoma 2Tracheal Neoplasms 1Solitary Pulmonary Nodule 1Pulmonary Sclerosing Hemangioma 1Prostatic Neoplasms 1Phyllodes Tumor 1Pancoast Syndrome 1

Interventions

pembrolizumab 8Paclitaxel 7Therapeutics 6Flow Cytometry 5Radiotherapy 4Polymerase Chain Reaction 4Filgrastim 4Docetaxel 4Carboplatin 4Psychiatric Rehabilitation 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Methylprednisolone 3Interleukin-12 Subunit p35 3Immunoenzyme Techniques 3Gene Expression Profiling 3Cyclophosphamide 3Cisplatin 3Amplified Fragment Length Polymorphism Analysis 3sargramostim 2liposomal amphotericin B 2aflibercept 2Trastuzumab 2Taxes 2Prednisone 2Ondansetron 2Itraconazole 2Irinotecan 2Immunologic Techniques 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × belinostat × Genitourinary × Clear all
NCT00421889 2015-07-28

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

Valerio Therapeutics

Phase 1/2 Completed
80 enrolled 19 charts
GenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡